George Siber

George Siber is the current Director & Chair of the Scientific Advisory Board at Genocea Biosciences. Prior to this, they were with Vaxxinity as their Chief Executive Officer.

George has also previously worked with Clover Biopharmaceuticals, Valneva, ClearSite Antibodies LLC, ILiAD Biotechnologies, AdVaccine, CureVac, Affinivax Inc., and Vaxess Technologies. George has over 25 years of experience in the biotech industry and has been instrumental in the development and commercialization of many vaccines.

George received their undergraduate degree from the University of Notre Dame and their PhD in microbiology from Dartmouth College. George did their post-doctoral work at Harvard Medical School.

George Siber attended McGill University and received their MD. George then completed their medical internship and residency at Rush Medical College of Rush University Medical Center. After this, they became a senior medical resident at Harvard Medical School. Siber eventually pursued a fellowship in vaccinology and infectious disease at Harvard Medical School.